Investing Profile

Matthew McAviney

InvestorVC
Partner at New Enterprise Associates (NEA)
nea.com/team/matt-mcaviney-mdSan Francisco, California
Photo of Matthew McAviney, Partner at New Enterprise Associates (NEA)

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$2.0M - $50.0M
$25.0M
6
$6.2B
CompanyStageDateRound SizeTotal Raised
Ouro Medicines
Series AJan 2025$120M
$120M
Co-investors: Shinichiro Fuse
AviadoBio
Series ADec 2021$78M
$78M
Sagimet Biosciences
Series UnknownFeb 2021$80M
$190M
Co-investors: Robert Garland (New Enterprise Associates (NEA)), David Mott (Mott Family Capital), Beth Seidenberg (Kleiner Perkins)
Recludix Pharma
SeedDec 2019
$60M
Co-investors: Carol Gallagher (New Enterprise Associates (NEA))
Korro Bio
SeedJan 2018
$210M
Co-investors: Ali Behbahani (New Enterprise Associates (NEA)), Jean-François Formela (Atlas Venture)
Moximed
SeedJan 2007
$200M
Co-investors: Josh Makower (New Enterprise Associates (NEA)), Tiffany Le (New Enterprise Associates (NEA)), Shahzad Malik (Advent Life Sciences)